skip navigation
NIH Record  
Vol. LXVI, No. 18
  August 29, 2014
Building the Future Today: NIA Summer Internship Program
Free Flu Vaccine Begins Sept. 15
NHLBI Inspires Next Generation of Minority Doctors, Researchers
Medoff-Cooper To Give NINR Director’s Lecture, Sept. 16
Wieczorek Named Credit Union CEO
printer friendly version
FDA Exits Campus This Summer After 73 Years

Bldg. 29 has long anchored the FDA presence on campus.
Bldg. 29 has long anchored the FDA presence on campus.

Owing to the Food and Drug Administration’s decision to consolidate its operations at a sprawling new campus in White Oak, FDA’s Center for Biologics Evaluation and Research (CBER) and Center for Drugs Evaluation and Research (CDER)—vestiges of which have lain at the heart of NIH’s campus for 73 years—will abandon the Bldg. 29 complex this summer.

The 29 complex consists of three buildings—all of which are interconnected—located just south of the Clinical Center: Bldg. 29, built in 1960; 29A, built in 1968; and 29B, constructed in 1994.

The NIH facilities working group has decided that Bldg. 29 will remain vacant while the Office of Research Facilities studies the cost-effectiveness of renovation. Bldg. 29A will be used as swing space to facilitate ongoing renovations of Bldg. 10. And 29B, the newest wing, will be occupied by NICHD, NIAID and NIMHD.

The exit plans have nothing to do with the discovery in July of some 327 vials of infectious agents in Bldg. 29A; those were found as part of preparations to move out.

NIBIB Welcomes Next Generation of Bioengineering, Bioimaging Researchers

Dr. Adam Cohen
Dr. Adam Cohen
Better, faster, cheaper technologies to improve health was the theme echoed throughout the second annual NIBIB Nagy Symposium, which recognized eight outstanding first-time NIBIB independent investigators who received the Edward C. Nagy New Investigator Award.

The award is named after the late founding executive director of the Academy of Radiology Research. The innovative research presented reflected Nagy’s tireless advocacy and vision for the creation of NIBIB, an institute to foster the development of state-of-the-art medical technologies that would support biomedical research across NIH.